12/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

12/2023

Dec 29, 2023, 16:07 | Positive
Amar Gajjar: Happy Holidays from the St. Jude Children’s Research Hospital brain tumor program
Amar Gajjar, Pediatric Neuro-Oncologist at St. Jude Children’s Research Hospital, shared on X/Twitter: "Happy Holidays…
Dec 29, 2023, 16:02 | Positive
Tatiana Prowell: Being an oncologist has taught me...
Tatiana Prowell shared a post by Débora Vendramini-Costa, Assistant Scientist at Henry Ford Pancreatic Cancer…
Dec 29, 2023, 15:57 | Insight
Robin Zon: Pay cuts are a potential threat to the integrity of the USA healthcare system
Robin Zon, Director of Breast Oncology at Cincinnati Cancer Advisors and President elect for ASCO, shared…
Dec 29, 2023, 15:53 | Opinion
Amer Zeidan: Why CROs shouldn’t be doing clinical research
Amer Zeidan shared on X: "If you have any doubt why CROs shouldn’t be doing…
Dec 29, 2023, 15:49 | Blog
Inspired by his desire to make a positive impact in the lives of those affected by cancer - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on X: "Inspired by his desire to make a positive…
Dec 29, 2023, 15:40 | Insight
Balazs Halmos: The docetaxel enigma continues
Balazs Halmos, Associate Director for Clinical Science at Montefiore Einstein Cancer Center, shared a post…
Dec 29, 2023, 15:35 | Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 29, 2023, 11:29 | Opinion
Vinay Prasad: How to read a science paper
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 29, 2023, 11:13 | Blog
Rami Manochakian: The 10 most-read articles of The ASCO Post in 2023
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "The 10 most-read…
Dec 29, 2023, 05:18 | Blog
U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on their X/Twitter page: ''Breaking from Journal of…
All: 654 Posts: 41 - 50